Investors locked in profits on MannKind Corp. (Nasdaq: MNKD). Shares of the inhalable insulin product maker plunged $1.01 to close at $2.79.
Profit taking sinks MannKind
January 26, 2018 at 18:07 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.